Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (587)	10/9/2001 5:13:23 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1833

UBS Warburg....... 800-759-8603, select #2, then #6, then #5........... "we are also told by another partner [presumably Solvay] that an adenosine blocker will go into CHF trials imminently" "respiratory program........ generating candidates....... compounds placed in the clinic next year" There was additional wording, but I need to pick up kids from schools and run off to soccer practice. If anyone can transcribe other wording, that would be great. Bottom line...... it sounds as if both programs are alive. I presume, BUT DO NOT KNOW, that a Solvay trial would trigger a very small milestone payment to KDUS.